Onyinyechi Lydia Ugorji

ORCID, self-asserted

ORCID 0000-0001-6397-9912

Publications

Citations

h-index

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

Publications

7 works in the graph, newest first.

Solidified reverse micellar solution-based chitosan-coated solid lipid nanoparticles as a new approach to enhance oral delivery of artemether in malaria treatment
2025BMC ChemistryJournalOpen access8 citations10.1186/s13065-025-01422-4
Preliminary in vitro investigation of docetaxel nanomedicines based on cetyl palmitate for inhibition of prostate cancer cells' growth
2025European Pharmaceutical JournalJournalOpen access0 citations10.2478/afpuc-2025-0008
Engineering 5-flourouracil and leucovorin-loaded vesicular systems for possible colon specific delivery: In vitro evaluation and real time cell assay against HCT-116 colon cell lines
2024HeliyonJournalOpen accessFirst author6 citations10.1016/j.heliyon.2024.e28872
Solubility enhancing lipid-based vehicles for artemether and lumefantrine destined for the possible treatment of induced malaria and inflammation: in vitro and in vivo evaluations
2024Beni-Suef University Journal of Basic and Applied SciencesJournalOpen accessFirst authorCorresponding3 citations10.1186/s43088-023-00446-w
Nanoparticle-based delivery systems as emerging therapy in retinoblastoma: recent advances, challenges and prospects
2023Nanoscale AdvancesJournalOpen access30 citations10.1039/d3na00462g
Soluplus-stabilized 5-fluorouracil-entrapped niosomal formulations prepared via active and passive loading techniques: comparative physico-chemical evaluation
2023Journal of Dispersion Science and TechnologyJournalFirst authorCorresponding2 citations10.1080/01932691.2023.2186427
The effect of niosome preparation methods in encapsulating 5-fluorouracil and real time cell assay against HCT-116 colon cancer cell line
2022HeliyonJournalOpen accessFirst authorCorresponding44 citations10.1016/j.heliyon.2022.e12369